BCB Medical, the Nordic forerunner in health data and clinical pathway solutions, is pleased to announce the appointment of Minna Palhamo as its new Chief Executive Officer, effective as of 14 May 2025. Palhamo brings a wealth of experience from healthcare, healthtech, and the pharmaceutical industry and will lead the company into its next phase of strategic development.
As CEO, Palhamo will continue to focus on evolving BCB’s exciting strategy of data supported decision-making. “I am honored to join BCB Medical at such a pivotal time,” says Palhamo. “Healthcare around the world is facing growing demands for efficiency, transparency, and improved patient outcomes. BCB’s ability to provide meaningful, structured data to support clinical decision-making and value-based care is more important than ever. I’m excited to build on the company’s strong foundation and bring our innovative solutions to a wider audience.”
Palhamo has deep understanding of the healthcare landscape, combined with strong track record of strategic vision, execution, and business development.
“We would like to thank Marcus Kaber for his valuable contribution as CEO and wish him every success in the future. At the same time we are thrilled to welcome Minna to lead BCB Medical,” says Ann-Christine Sundell, the company’s Chair of Board. “Her deep expertise and visionary approach to digital health will be instrumental in driving our mission to improve healthcare outcomes through data-driven insights.”
BCB Medical is committed to shaping the future of healthcare by delivering advanced, real-world data solutions that empower professionals and organizations in the wellbeing services counties to make better-informed decisions.
